Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Duration of Anticoagulation After Femur Fracture Repair

Standard Duration Recommendations

  • Anticoagulation should be administered for a minimum of 10-14 days after femur fracture repair, with consideration for extended prophylaxis up to 35 days for patients at higher risk for VTE, as recommended by the American College of Physicians 1
  • The risk of VTE after orthopedic surgery can persist for up to 2 months postoperatively, supporting the rationale for extended prophylaxis 2

Anticoagulation Options

  • Low-molecular-weight heparin (LMWH) is the preferred agent with the first dose given at least 12 hours after surgery, according to the American College of Cardiology 1
  • Direct oral anticoagulants (DOACs) like rivaroxaban and apixaban are also effective options, with a strength of evidence rated as high 3

Administration Timing

  • For LMWH, the first dose should be administered at least 12 hours from the time of surgery, as recommended by the American College of Surgeons 1
  • DOACs should be started 12-24 hours after surgery when hemostasis is achieved, with a moderate strength of evidence 2

Risk Stratification for Extended Prophylaxis

  • Extended prophylaxis (up to 35 days) should be considered for patients with a history of previous VTE, active cancer, or limited mobility, as recommended by the American College of Physicians 1
  • Patients with elevated D-dimer (>2 times upper limit of normal) should also be considered for extended prophylaxis, with a low strength of evidence 4

Special Considerations

  • Tinzaparin may be safer compared to other agents in patients with renal impairment, with a moderate strength of evidence 3
  • Intermittent pneumatic compression (IPC) for a goal of 18 hours daily is recommended in addition to anticoagulant therapy, as recommended by the American College of Surgeons 1

Post-Discharge Prophylaxis

  • FDA-approved post-discharge prophylactic anticoagulation regimens (rivaroxaban and betrixaban) should be considered in patients with high VTE risk and low bleeding risk, with a high strength of evidence 5
  • The recommended duration for post-discharge prophylaxis is 31-39 days for rivaroxaban and 35-42 days for betrixaban, with a moderate strength of evidence 5

Monitoring Recommendations

  • Regular monitoring of platelet counts is recommended due to potential thrombocytopenia with anticoagulant use, as recommended by the American College of Physicians 1
  • Periodic assessment of renal function is important, especially for medications with renal clearance, with a low strength of evidence 3

Common Pitfalls to Avoid

  • Inadequate duration of prophylaxis is a common pitfall, despite guidelines recommending extended prophylaxis, with a high strength of evidence 3
  • Failure to adjust for renal function can lead to bleeding complications, with a moderate strength of evidence 3
  • Neglecting mechanical prophylaxis can increase the risk of VTE, with a low strength of evidence 1